USFDA expands EUA for Eli Lilly bamlanivimab with etesevimab Ruchika Sharma5 Dec 2021 10:30 AM ISTIndianapolis: Eli Lilly has recently announced that U.S. Food and Drug Administration (USFDA) has expanded the Emergency Use Authorization...
Bamlanivimab reduces risk of COVID-19 Infection: JAMA Study MD Bureau8 July 2021 9:00 AM ISTBamlanivimab monotherapy reduces the incidence of COVID-19 infection, according to a clinical trial.
Bamlanivimab may help prevent COVID-19 infection, finds JAMA study Dr Sravan Kumar7 Jun 2021 11:16 AM ISTWhile the emergence of efficacious vaccines is a critical step in addressing the COVID-19 pandemic, other preventive interventions, such as passive...
Eli Lilly antibody drugs bamlanivimab, etesevimab get nod for use in India Ruchika Sharma1 Jun 2021 12:00 PM ISTNew Delhi: Eli Lilly and Company India said on Tuesday it has received permission for restricted emergency use of its antibody drugs bamlanivimab 700...
Eli Lilly to supply 650,000 additional Covid doses to US Govt Ruchika Sharma4 Dec 2020 10:00 AM ISTNew Delhi: Eli Lilly and Co said on Wednesday the U.S. government has purchased 650,000 additional doses of its Covid-19 antibody drug for $812.5...
IDSA's updated guidelines on COVID-19 released MD Bureau26 Nov 2020 4:00 PM ISTInfectious Disease Society of America (IDSA) has been releasing new approach and recommendation for managing COVID-19 at regular...
Eli Lilly neutralizing antibody gets USFDA emergency use authorization for Covid treatment Ruchika Sharma11 Nov 2020 6:47 PM ISTIndianapolis: The U.S. Food and Drug Administration (USFDA) recently granted Emergency Use Authorization (EUA) for Eli Lilly and Company's...
